Papaverine plus prostaglandin e1 versus prostaglandin e1 alone for intracorporeal injection therapy

International Urology and Nephrology

Volumn 30, Issue 2, 1998, Pages 193-196

  Zaher, T F ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

PAPAVERINE; PROSTAGLANDIN E1;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; IMPOTENCE; INJECTION PAIN; INTRACAVERNOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; PRIAPISM; TREATMENT OUTCOME;

EID: 0031754024     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02550576     Document Type: Article

References (11)

1. Althof, S. E., Turner, L. A., Levine, S. B , Risen, C., Kursh, E., Bodner, D., Resnick, M.: Why do so many people drop out from auto-injection therapy for impotence? J. Sex. Marital. Ther., 15, 121 (1989).
2. Bennett, A. H., Carpenter, A. J., Barada, J. H.: An improved vasoactive drug combination for a pharmacological erection program. J. Urol., 146, 1564 (1991).
3. Brindley, G. S.: Cavernosal alpha-blockade: A new technique for investigating and treating erectile impotence. Br. J. Psychiatr., 43, 332 (1983).
4. 1 alone. J. Urol., 145, 56 (1991).
5. Hedlund, H., Anderson, K.-E.: Contraction and relaxation induced by some protanoids in isolated human penile erectile tissue and cavernous artery. J. Urol., 134, 245 (1985).
6. Lakin, M. M., Mondague, D. K., Vander Brug Medendorp, S., Tesar, L., Schover, L. R.: Intracavernous injection therapy, analysis of results and complications. J. Urol., 143, 1138 (1990).
7. Levine, S. B., Althof, S. E., Turner, L. A., Risen, C. B., Bodner, D. R., Kursh, E. D., Resnick, M. I.: Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. J. Urol., 141, 54 (1989).
8. Sidi, A. A., Chen, K. K.: Clinical experience with vasoactive intracavernous pharmacotherapy for the treatment of impotence. World J. Urol., 5, 156 (1987).
9. 1 versus papaverine-phentolamine alone for intracorporeal injection therapy: A clinical double blind study. J. Urol., 154, 1017 (1995).
10. Von-Heyden, B., Donatucci, C. F., Kaula, N., Lue, T. F.: Intracavernous pharmacotherapy for impotence: Selection of appropriate agent and dose. J. Urol., 149, 1288 (1993).
11. Zentgraf, M., Ludiving, G., Ziegler, M.: How safe is the treatment of impotence with intracavernous autoinjection? Eur. Urol., 16, 165 (1989).